Literature DB >> 15229073

Worsening schizoaffective disorder with aripiprazole.

Roy R Reeves, James E Mack.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15229073     DOI: 10.1176/appi.ajp.161.7.1308

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  9 in total

1.  Aripiprazole worsens psychosis: a case report.

Authors:  Sandeep Grover; Pratap Sharan; Nitin Gupta
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

2.  Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide.

Authors:  François Montastruc; Rui Nie; Simone Loo; Soham Rej; Sophie Dell'Aniello; Joëlle Micallef; Samy Suissa; Christel Renoux
Journal:  JAMA Psychiatry       Date:  2019-04-01       Impact factor: 21.596

3.  Predictors of early worsening after switch to aripiprazole: a randomized, controlled, open-label study.

Authors:  Chi-Un Pae; Alberto Chiesa; Laura Mandelli; Ashwin A Patkar; Sara Gibiino; Alessandro Serretti
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

4.  HTR2A A-1438G/T102C polymorphisms predict negative symptoms performance upon aripiprazole treatment in schizophrenic patients.

Authors:  Shih-Fen Chen; Yu-Chih Shen; Chia-Hsiang Chen
Journal:  Psychopharmacology (Berl)       Date:  2009-04-23       Impact factor: 4.530

Review 5.  A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorder.

Authors:  Hiroyoshi Takeuchi; Gary Remington
Journal:  Psychopharmacology (Berl)       Date:  2013-06-05       Impact factor: 4.530

6.  Role of aripiprazole in treatment-resistant schizophrenia.

Authors:  Nilufar Mossaheb; Rainer M Kaufmann
Journal:  Neuropsychiatr Dis Treat       Date:  2012-05-29       Impact factor: 2.570

Review 7.  Polypharmacy in pediatric patients and opportunities for pharmacists' involvement.

Authors:  Alexis E Horace; Fahamina Ahmed
Journal:  Integr Pharm Res Pract       Date:  2015-08-21

8.  A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder.

Authors:  Leslie Citrome
Journal:  Neuropsychiatr Dis Treat       Date:  2006-12       Impact factor: 2.570

9.  Aripiprazole monotherapy in an adolescent worsens psychosis.

Authors:  Mahima Panigrahi; Susanta Kumar Padhy; Rajesh Rathi
Journal:  Indian J Pharmacol       Date:  2013 Mar-Apr       Impact factor: 1.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.